Tradename | Proper name | Company | Number | Date | Products |
---|---|---|---|---|---|
Hylenex recombinant | hyaluronidase human | Halozyme Therapeutics | N-21859 RX | 2005-12-02 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
darzalex faspro | Biologic Licensing Application | 2024-08-08 |
herceptin hylecta | Biologic Licensing Application | 2024-11-21 |
hylenex recombinant | Biologic Licensing Application | 2024-11-11 |
phesgo | Biologic Licensing Application | 2024-12-02 |
vyvgart hytrulo | Biologic Licensing Application | 2025-04-14 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Melanoma | D008545 | — | — | — | 2 | 2 | — | — | 4 |
Skin neoplasms | D012878 | EFO_0004198 | C44 | 1 | — | 1 | — | — | 2 |
Renal cell carcinoma | D002292 | EFO_0000376 | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 5 | 3 | — | — | — | 5 |
Neoplasms by site | D009371 | — | — | 1 | 1 | — | — | — | 1 |
Urologic neoplasms | D014571 | — | C64-C68 | — | 1 | — | — | — | 1 |
Transitional cell carcinoma | D002295 | — | — | — | 1 | — | — | — | 1 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | — | 1 | — | — | — | 1 |
Patient preference | D057240 | — | — | — | 1 | — | — | — | 1 |
Multiple myeloma | D009101 | — | C90.0 | — | 1 | — | — | — | 1 |
Plasma cell neoplasms | D054219 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lung neoplasms | D008175 | — | C34.90 | 1 | — | — | — | — | 1 |
Urinary bladder neoplasms | D001749 | — | C67 | 1 | — | — | — | — | 1 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 1 | — | — | — | — | 1 |
Kidney neoplasms | D007680 | EFO_0003865 | C64 | 1 | — | — | — | — | 1 |
Drug common name | Hyaluronidase (human recombinant) |
INN | vorhyaluronidase alfa |
Description | Hyaluronidase (human recombinant) is an enzyme pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Enzyme |
Drug class | enzymes |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1201718 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 743QUY4VD8 (ChemIDplus, GSRS) |